ALPPS	associating liver partition and portal vein ligation for staged hepatectomy
BrdU	bromodeoxyuridine 5-bromo-2’-deoxyuridine
BubR1	budding uninhibited by benzimidazole-related 1
C/EBP	CCAAT/enhancer-binding protein
CNI	calcineurin inhibitor
CyA	cyclosporine A
EGF	epidermal growth factor
EFGR	epidermal growth factor receptor
eNOS	endothelial nitric oxide synthetase
eIF4E	eukaryotic translation initiation factor 4E
FGF	fibroblast growth factor
FXR	farnesoid X receptor
GH	growth hormone
Gp	glycoprotein
HGF	hepatic growth factor
HIF-1α	hypoxia-inducible factor-1alpha
HSCs	hepatic stellate cells
IFN	interferon
IL	interleukin
iNOS	inducible nitric oxide synthetase
JAK	Janus kinase
LATS1/2	large tumor suppressor 1/2
LPCs	liver progenitor cells
LPS	lipopolysaccharide
LSECs	liver sinusoidal endothelial cells
MCDD	methionine- and choline-deficient diet
MMF	mycophenolate mofetil
MST1/2	mammalian Ste20-like kinases 1/2
mTOR	mammalian/mechanistic target of rapamycin
NF-κB	nuclear factor-κB
NK	natural killer cells
NO	nitric oxide
PAMPs	pathogen-associated molecular patterns
PCNA	proliferating cell nuclear antigen
PHx	partial hepatectomy
PI3K	phosphatidylinositol 3’-kinase
PLTx	partial liver transplantation
PRRs	pattern recognition receptors
PVL+T	portal vein ligation + hepatic transection
PVP	portal venous pressure
RTK	receptor tyrosine kinase
sIL-6R	soluble IL-6 receptor
S6Ks	S6 kinase
STAT	signal transducer and activator of transcription
TAZ	transcriptional coactivator with PDZ-binding motif
TEAD	transcriptional enhanced associate domain
TGF	transforming growth factor
TLRs	Toll-like receptors
TNF	tumor necrosis factor
VEGF	vascular endothelial growth factor
YAP	Yes-associated protein
4E-BPs	eIF4E-binding proteins